The Claim
Exposure to BDE-47 in BALB/c mice is associated with downregulation of PPARα and its target genes Cpt1 and Cyp4a1, resulting in impaired β-oxidation and ω-oxidation of fatty acids, which may contribute to hepatic lipid accumulation and the development of MASLD.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When these lab mice are exposed to a chemical called BDE-47, it might slow down their liver's ability to burn fat, leading to fat buildup that could cause a type of liver disease.
See the scientific wording
BDE-47 exposure in BALB/c mice is associated with downregulation of PPARα and its target genes Cpt1 and Cyp4a1, leading to impaired β- and ω-oxidation of fatty acids, which may contribute to hepatic lipid accumulation and MASLD.
What the research says
1 studyThe study shows that when mice are exposed to BDE-47, their liver processes for burning fat slow down because key genes are turned down, leading to fat buildup in the liver — exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.